Advisor OS LLC Has $627,000 Position in The Clorox Company (NYSE:CLX)

Advisor OS LLC raised its holdings in The Clorox Company (NYSE:CLX) by 48.1% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 4,594 shares of the company’s stock after acquiring an additional 1,493 shares during the quarter. Advisor OS LLC’s holdings in Clorox were worth $627,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. CIBC Private Wealth Group LLC raised its position in Clorox by 0.5% in the fourth quarter. CIBC Private Wealth Group LLC now owns 13,900 shares of the company’s stock worth $1,982,000 after acquiring an additional 66 shares during the period. Lindbrook Capital LLC raised its position in shares of Clorox by 6.2% in the first quarter. Lindbrook Capital LLC now owns 1,182 shares of the company’s stock valued at $181,000 after purchasing an additional 69 shares during the period. Blue Trust Inc. grew its stake in Clorox by 14.3% during the second quarter. Blue Trust Inc. now owns 678 shares of the company’s stock valued at $93,000 after acquiring an additional 85 shares in the last quarter. First National Bank of Omaha grew its stake in Clorox by 1.5% during the fourth quarter. First National Bank of Omaha now owns 5,975 shares of the company’s stock valued at $852,000 after acquiring an additional 86 shares in the last quarter. Finally, Diversify Advisory Services LLC grew its stake in Clorox by 3.9% during the second quarter. Diversify Advisory Services LLC now owns 2,441 shares of the company’s stock valued at $322,000 after acquiring an additional 92 shares in the last quarter. 78.53% of the stock is owned by institutional investors.

Clorox Stock Performance

Shares of CLX stock opened at $164.75 on Friday. The Clorox Company has a one year low of $114.68 and a one year high of $166.49. The company’s 50-day moving average is $142.93 and its 200 day moving average is $142.85. The company has a market capitalization of $20.46 billion, a price-to-earnings ratio of 85.36, a price-to-earnings-growth ratio of 3.21 and a beta of 0.40. The company has a debt-to-equity ratio of 5.04, a quick ratio of 0.63 and a current ratio of 1.03.

Clorox (NYSE:CLX) last announced its quarterly earnings data on Thursday, August 1st. The company reported $1.82 EPS for the quarter, beating the consensus estimate of $1.54 by $0.28. The company had revenue of $1.90 billion for the quarter, compared to the consensus estimate of $1.97 billion. Clorox had a net margin of 3.95% and a return on equity of 281.12%. Sell-side analysts expect that The Clorox Company will post 6.56 EPS for the current fiscal year.

Clorox Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, August 30th. Stockholders of record on Wednesday, August 14th were paid a $1.22 dividend. This represents a $4.88 annualized dividend and a dividend yield of 2.96%. The ex-dividend date was Tuesday, August 13th. This is a boost from Clorox’s previous quarterly dividend of $1.20. Clorox’s dividend payout ratio is 252.85%.

Analyst Ratings Changes

A number of equities analysts have commented on CLX shares. Deutsche Bank Aktiengesellschaft boosted their price target on shares of Clorox from $144.00 to $151.00 and gave the stock a “hold” rating in a research note on Friday, August 2nd. JPMorgan Chase & Co. cut their price objective on shares of Clorox from $150.00 to $148.00 and set a “neutral” rating for the company in a research note on Friday, August 2nd. Wells Fargo & Company cut their price objective on shares of Clorox from $135.00 to $130.00 and set an “underweight” rating for the company in a research note on Wednesday, July 10th. DA Davidson reaffirmed a “neutral” rating and issued a $153.00 price objective on shares of Clorox in a research note on Friday. Finally, TD Cowen initiated coverage on shares of Clorox in a report on Tuesday, July 23rd. They set a “sell” rating and a $122.00 price target for the company. Six equities research analysts have rated the stock with a sell rating and thirteen have given a hold rating to the company’s stock. Based on data from MarketBeat.com, Clorox has a consensus rating of “Hold” and an average price target of $143.50.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.